Connection
Calen Steiner to Protein Kinase Inhibitors
This is a "connection" page, showing publications Calen Steiner has written about Protein Kinase Inhibitors.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.250 |
|
|
|
-
Saeedi BJ, Carr HE, Higgins PDR, Steiner CA. AXL: A novel therapeutic target in IBD. Adv Pharmacol. 2024; 101:141-157.
Score: 0.150
-
Berinstein JA, Steiner CA, Regal RE, Allen JI, Kinnucan JAR, Stidham RW, Waljee AK, Bishu S, Aldrich LB, Higgins PDR. Efficacy of Induction Therapy With High-Intensity Tofacitinib in 4 Patients With Acute Severe Ulcerative Colitis. Clin Gastroenterol Hepatol. 2019 04; 17(5):988-990.e1.
Score: 0.100